Reimagining Druggability Using Chemoproteomic Platforms
2021 · Accounts of Chemical Research · 179 citations
https://doi.org/10.1021/acs.accounts.1c00065
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
807
Citations
6
h-index
5
i10-index
Erika Zhang is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways & Multiple Myeloma Research and Treatments. The author has an h-index of 6, co-authored 8 publications.
ORCID: 0000-0002-7123-8046Click to start Chat